MedPath

The Protective Effect of Mask Wearing Against Respiratory Tract Infections

Not Applicable
Completed
Conditions
COVID-19
Respiratory Tract Infections
Interventions
Behavioral: Wearing face masks
Registration Number
NCT05690516
Lead Sponsor
Norwegian Institute of Public Health
Brief Summary

In this trial the researchers plan to recruit 4,000 volunteers to be randomly allocated either wearing face masks in public spaces where they are close to other people, or not wear face masks in such circumstances. For each participant the trial period is 2 weeks, after which they will be asked to complete a brief questionnaire which includes questions about whether they experienced the common cold, influenzas or COVID-19 symptoms during the trail period.

Detailed Description

This study is a pragmatic, two-armed cluster randomized superiority trial including participants in Norway. Participants will be randomized to one of the following two arms: control group or medical masks in a 1:1 ratio. The primary outcome is self-reported respiratory infection.

The intervention is to ask participants in the intervention groups to wear face masks when close to others outside their home, e.g., in public spaces like shopping centres, and streets and on public transport. The control group will be asked not to wear face masks when close to others outside their home, e.g., in public spaces like shopping centres, and streets and on public transport. Participants will continue to use, or not use, face masks at work independent of which group they are allocated to.

The trial will be fully remote and without any personal interaction between investigators and participants.

The researchers aim to include about 4,000 participants to have a statistical power of 80% to detect a relative risk reduction of 30% for the primary outcome.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4575
Inclusion Criteria
  • Are at least 18 years of age
  • Are willing to be randomized to wear, or not to wear, face masks outside their home when close to others for a 14-day period
  • Provide informed consent
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Face masksWearing face masksParticipants in the experimental arm are asked to wear face masks when close to others outside their home, e.g., in public spaces like shopping centres, and streets and on public transport.
Primary Outcome Measures
NameTimeMethod
Respiratory symptoms of the common cold, influenza or COVID-19Day 1 to 17

Self-report

Secondary Outcome Measures
NameTimeMethod
Positive test for SARS-CoV-2Day 3 to 17 after start of tiral period

We will compare the incidence of notified cases of COVID-19 (i.e. registered positive SARS-CoV-tests)

Covid-19 prevalenceDay 1 to 17

Self-report

Health care use for injuriesDay 1 to 17

Self-report

Health care use for respiratory symptomsDay 1 to 17

Self-report

Health care use (all causes)Day 1 to 17

Self-report

Trial Locations

Locations (1)

Norwegian Institute of Public Health

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath